Also trades as: PMCUF (OTC) · $vol 0M

A$159.69 ($110.92)

+3.31 (+2.12%)

Weekly Expected Move ±3.3%

A$146 A$151 A$156 A$162 A$167

ASX · Healthcare · Medical - Healthcare Information Services · Tech Score Sell · Power 34 · A$16.3B mcap · 53M float · 0.542% daily turnover

Revenue

$262M +22.9% ▲

5Y CAGR: +31.0%

Gross Profit

$211M -0.7% ▼

5Y CAGR: +35.2%

Operating Income

$196M +24.4% ▲

5Y CAGR: +35.9%

Net Income

$265M +130.3% ▲

5Y CAGR: +53.8%

EPS (Diluted)

$2.54 +130.9% ▲

5Y CAGR: +53.3%

EBITDA

$204M +23.9% ▲

5Y CAGR: +32.7%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$93M	$125M	$161M	$213M	$262M
YoY Growth	+37.7%	+33.6%	+29.2%	+31.9%	+22.9%
Cost of Revenue	$23M	$33M	$39M	$309K	$51M
Gross Profit	$93M	$92M	$122M	$213M	$211M
Gross Margin	99.4%	74.0%	75.7%	99.9%	80.7%
R&D Expenses	$7M	$7M	$8M	$0	$0
SG&A Expenses	$17M	$27M	$33M	$40M	$15M
Operating Expenses	$31M	$40M	$49M	$55M	$15M
Operating Income	$62M	$84M	$112M	$158M	$196M
Operating Margin	66.8%	67.2%	69.5%	74.0%	74.9%
Interest Expense	$0	$0	$0	$0	$0
Income Before Tax	$63M	$86M	$116M	$163M	$378M
Tax Expense	$19M	$25M	$34M	$48M	$112M
Net Income	$44M	$61M	$83M	$115M	$265M
Net Margin	47.6%	48.6%	51.3%	54.1%	101.4%
EPS (Diluted)	$0.43	$0.58	$0.79	$1.10	$2.54
EBITDA	$70M	$92M	$121M	$165M	$204M
Shares Outstanding	105M	105M	105M	105M	105M

Line Item	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2	FY2026 Q4
Revenue	$57M	$68M	$74M	$87M	$97M	$116M	$125M	$137M
Cost of Revenue	$15M	$17M	$19M	$20M	$20M	$23M	$29M	$22M
Gross Profit	$42M	$51M	$55M	$68M	$77M	$92M	$96M	$115M
Gross Margin	73.2%	74.6%	73.7%	77.5%	78.9%	79.8%	77.1%	84.0%
R&D Expenses	$3M	$4M	$4M	$0	$3M	$4M	$0	$0
SG&A Expenses	$4M	$4M	$6M	$4M	$7M	$5M	$5M	$10M
Operating Expenses	$4M	$4M	$6M	$4M	$7M	$5M	$5M	$10M
Operating Income	$37M	$47M	$49M	$63M	$70M	$88M	$91M	$105M
Operating Margin	65.4%	68.6%	66.0%	72.5%	71.9%	75.8%	72.7%	77.0%
Interest Expense	$0	$0	$0	$0	$0	$0	$0	$0
Income Before Tax	$38M	$48M	$50M	$66M	$73M	$90M	$243M	$134M
Tax Expense	$11M	$15M	$14M	$20M	$22M	$27M	$72M	$40M
Net Income	$27M	$33M	$36M	$47M	$52M	$63M	$171M	$94M
Net Margin	47.8%	49.2%	48.9%	53.3%	53.2%	54.8%	137.2%	68.7%
EPS (Diluted)	$0.26	$0.32	$0.35	$0.45	$0.49	$0.61	$1.64	$0.90
EBITDA	$42M	$52M	$55M	$70M	$76M	$94M	$94M	$110M
Shares Outstanding	105M	104M	105M	105M	105M	105M	105M	105M

PME.AX ASX